Andrew Schwab
Director/Board Member chez SKYE BIOSCIENCE, INC.
Fortune : - $ au 31/03/2024
Profil
Andrew J.
Schwab founded 5AM Venture Management LLC in 2002, where he is working as Managing Partner from 2014.
Mr. Schwab also currently works at Skye Bioscience, Inc., as Director from 2023, Presidio Terrace, as Director, Fellow Health, Inc., as Director, and various other companies.
Mr. Schwab also formerly worked at 5:01 Acquisition Corp., as Co-Chief Executive Officer & Director, Bird Rock Bio Sub, Inc., as Chairman, Panomics LLC, as Director, and various other companies.
Mr. Schwab received his undergraduate degree in 1993 from Davidson College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SKYE BIOSCIENCE, INC.
-.--% | 13/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
| 01/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Andrew Schwab
| Sociétés | Poste | Début |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Director/Board Member | 18/08/2023 |
| Davidson College | Director/Board Member | - |
| 5AM Partners LLC | Corporate Officer/Principal | - |
| 5AM Partners II LLC | Corporate Officer/Principal | - |
| 5AM Partners III LLC | Corporate Officer/Principal | - |
| 5am Partners IV LLC | Corporate Officer/Principal | - |
| 5AM Partners V LLC | Corporate Officer/Principal | - |
| 5AM Opportunities I GP LLC | Corporate Officer/Principal | - |
| Presidio Terrace | Director/Board Member | - |
| ░░░ ░░░░░░░░ ░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Anciens postes connus de Andrew Schwab
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░ ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Andrew Schwab
| Davidson College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| VIVEVE MEDICAL, INC. | Health Technology |
| SKYE BIOSCIENCE, INC. | Health Technology |
| PEAR THERAPEUTICS, INC. | Health Technology |
| ENLIVEN THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 40 |
|---|---|
Panomics LLC
 Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Commercial Services |
Miikana Therapeutics, Inc.
 Miikana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Miikana Therapeutics, Inc. develops therapeutics for the treatment of cancer and inflammatory diseases. It is a biopharmaceutical company focused on development and discovery of novel oncology drugs. It also performs its own research and licenses other companies. The company was founded in 2002 by Tak Mak, Dinesh Patel and S. Gail Eckhardt and is headquartered in Fremont, CA. | Health Technology |
Viveve, Inc.
 Viveve, Inc. Medical SpecialtiesHealth Technology Viveve, Inc. engages in the development of medical devices that promote personal health and wellness. It offers InControl products and Viveve system solutions. The company was founded by Jonathan B. Parmer in 2005 and is headquartered in Englewood, CO. | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Synosia Therapeutics develops and intends to commercialize innovative products for unmet medical needs in psychiatry and neurology. The firm is working to extend the reach of marketed and clinical-stage compounds, acquired through strategic partnerships with Novartis, Roche and Syngenta, into new indications with significant potential. Founded in December 2005 and headquartered in Switzerland, Synosia is managed by a highly experienced management team with some 200 years of drug development experience. The company is backed by $62 million in funding from high-quality investors and has a rich portfolio of compounds. | Health Technology |
The Assay Depot, Inc.
 The Assay Depot, Inc. Miscellaneous Commercial ServicesCommercial Services The Assay Depot, Inc. operates as a network of public and private e-commerce marketplaces that connect buyers and sellers of scientific research services. It serves large and small pharmaceutical companies, government institutes, biotechnology companies, academic researchers and citizen scientists. The company was founded by Christopher L. Petersen, Andrew B. Martin, and Kevin D. Lustig in 2007 and is headquartered in Solana Beach, CA. | Commercial Services |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Biotie Therapies AG
 Biotie Therapies AG Pharmaceuticals: MajorHealth Technology Part of Acorda Therapeutics, Inc., Biotie Therapies AG is a holding Swiss company focused on developing drugs for the treatment of psychiatry and neurology diseases. The private company is based in Zurich, Switzerland. | Health Technology |
BlueLight Therapeutics, Inc.
 BlueLight Therapeutics, Inc. BiotechnologyHealth Technology BlueLight Therapeutics, Inc. develops novel systems to analyze real-time protein function for research and clinical applications. The firm offers technology for detecting conformational change in proteins and other biological molecules. Its technology is based on a phenomenon called second-harmonic generation (SHG), can monitor structural changes at any site within a protein, in real time and since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into how the body functions and respond to treatments. The company was founded by Joshua S. Salafsky and Greg S. Yap in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
DVS Sciences, Inc.
 DVS Sciences, Inc. Medical DistributorsDistribution Services DVS Sciences Inc. develops analytical equipment and reagent for CyTOF instrument. The company was founded by Dmitry Bandura, Vladimir Baranov, Scott Tanner and olga Ornatsky in 2004 and is headquartered in Sunnyvale, CA. | Distribution Services |
Purigen Biosystems, Inc.
 Purigen Biosystems, Inc. BiotechnologyHealth Technology Purigen Biosystems, Inc. engages in extracting, enriching and quantifying DNA and RNA from biological samples. The company was founded in 2012 by Amy Hiddessen, Klint Rose and Juan Santiago and is headquartered in Pleasanton, CA. | Health Technology |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Biotie Therapies Oy engages in the research, development, and commercialization of pharmaceutical products. The company was founded by Markku Tapani Jalkanen and Sirpa Tuulikki Jalkanen in June 1992 and is headquartered in Helsinki, Finland. | Health Technology |
| Montgomery Securities, Inc. | Finance |
Digital Gene Technologies, Inc.
 Digital Gene Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Digital Gene Technologies, Inc. develops technology designed to enable researchers to measure gene expression levels in various disease models. The company is headquartered in La Jolla, CA. | Electronic Technology |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Health Technology |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in San Rafael, California. | Finance |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Commercial Services |
The California Academy of Sciences
 The California Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The California Academy of Sciences operates as a scientific and cultural institution. The Academy houses an aquarium, a planetarium a natural history museum and a rainforest. It was founded in 1853 and is headquartered in San Francisco, CA. | Commercial Services |
| 5AM Partners II LLC | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
| 5AM Partners III LLC | |
| 5AM Partners LLC | |
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Health Technology |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Precision NanoSystems, Inc.
 Precision NanoSystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Precision NanoSystems, Inc. manufactures equipment related to testing electricity and electrical Signals. It develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. The company was founded by Robert James Taylor and Euan Ramsay in 2010 and is headquartered in Vancouver, Canada. | Electronic Technology |
| 5am Partners IV LLC | |
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Technology Services |
| 5AM Partners V LLC | |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Health Technology |
| 5AM Opportunities I GP LLC | |
Nido Biosciences, Inc.
 Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Health Technology |
TMRW Life Sciences, Inc.
 TMRW Life Sciences, Inc. Information Technology ServicesTechnology Services TMRW Life Sciences, Inc. operates as a platform for in-clinic and remote storage. The company was founded by Joshua Abram, Alan Murray and Jeffrey Port and is headquartered in New York, NY. | Technology Services |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance 5:01 Acquisition Corp. is a blank check emerging growth company that was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 31, 2020 and is headquartered in San Francisco, CA. | Finance |
| 5am Partners Vi LLC | |
| Presidio Terrace | |
Fellow Health, Inc.
 Fellow Health, Inc. Medical SpecialtiesHealth Technology Fellow Health, Inc. is a company that offers at-home fertility testing for men. Fellow Health is based in San Leandro, CA and was founded by Graham Gilkerson and William Matthews. The company's service allows men to test their sperm privately from home and receive a doctor-reviewed male fertility report with detailed semen analysis results. In addition to their at-home testing service, the company also helps clinicians streamline their workflows and improve patient experience. William Matthews has been the CEO since incorporation. | Health Technology |
Radionetics Oncology, Inc.
 Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Radionetics Oncology, Inc. is a clinical stage radiopharmaceutical company based in Menlo Park, CA. Radionetics Oncology, Inc. focuses on the discovery and development of novel radiotherapeutics for the treatment of various oncology indications. Radionetics Oncology spun out of Crinetics Pharmaceuticals and is supported by Frazier Life Sciences, 5AM Ventures, DCVC Bio, Crinetics Pharmaceuticals, and GordonMD Investments. The company is advancing a pipeline of small molecule radioligands that target G-protein coupled receptors to treat a wide range of cancers, including adrenocortical carcinoma, breast cancer, and lung cancer. The company's platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes selectively to tumors expressing peptide receptors. The company's pipeline consists of multiple lead drug candidates, and they are conducting additional drug discovery efforts in collaboration with Crinetics Pharmaceuticals. The market for radiopharmaceuticals is expected to rise to $12.6 billion by 2027. The company was founded by Scott R. Struthers, and Paul A. Grayson has been the CEO since 2024. | Health Technology |
